# TRex Bio (TRXB) — News

TRXB · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/trxb/news

## Recent headlines

- [Trex Bio opens at $13.50, IPO at $14](https://www.ainvest.com/news/trex-bio-opens-13-50-ipo-14-2610) — AInvest Wire, Oct 9, 2026
  Trex Bio (NASDAQ: TXBIO) opened trading on October 9, 2026, at $13.50 per share, below its initial public offering (IPO) price of $14. The company’s stock debuted on the NASDAQ following a $150 million IPO that raised capital for its pipeline of biologic therapies targeting autoimmune and…
- [Trex Bio shares indicated at $13.90; IPO price $14](https://www.ainvest.com/news/trex-bio-shares-13-90-ipo-price-14-2610) — AInvest Wire, Oct 9, 2026
  Trex Bio (NASDAQ: TXBio) shares opened at $13.90 on October 9, 2026, slightly below the initial public offering (IPO) price of $14 per share[1]. The stock's opening price reflects early market sentiment following its recent public listing. The company, which focuses on biotechnology innovation,…
- [Trex Bio indicated at $14.05; IPO price $14](https://www.ainvest.com/news/trex-bio-14-05-ipo-price-14-2610) — AInvest Wire, Oct 9, 2026
  Trex Bio, Inc. (TRXB) marked its initial public offering (IPO) with a stock price of $14 per share, aligning closely with its opening price of $14.05 . The company announced plans to offer 8.33 million shares at a range of $14 to $16 per share. As a biotechnology firm, TRex Bio is focused on…
- [Trex Bio indicated at $14.50; IPO price $14](https://www.ainvest.com/news/trex-bio-14-50-ipo-price-14-2610) — AInvest Wire, Oct 9, 2026
  Trex Bio has set an initial public offering (IPO) price of $14 per share, slightly below its indicated price of $14.50, according to recent filings. The clinical-stage biopharmaceutical company is seeking to raise capital to advance its pipeline of therapies targeting autoimmune and inflammatory…
- [Quotation resumed: (TRXB) IPO security released for quotation](https://www.ainvest.com/news/quotation-resumed-trxb-ipo-security-released-quotation-2610) — AInvest Wire, Oct 9, 2026
  TRex Bio Inc. (TRXB) has resumed quotation for its upcoming initial public offering (IPO), following the announcement of its proposed $125 million offering. The biotechnology firm, supported by Eli Lilly & Co., plans to issue 8.33 million shares at a price range of $14.00 to $16.00 per share, with…

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).